|
|||||
|
|
Relative Efficacy of Sacubitril-Valsartan,Vericiguat, and SGLT2 Inhibitors in Heart Failure with Reduced Ejection Fraction: a Systematic Review and Network Meta-Analysis |
|
| Authors: | Aimo Alberto Pateras Konstantinos Stamatelopoulos Kimon Bayes-Genis Antoni Lombardi Carlo Mario Passino Claudio Emdin Michele Georgiopoulos Georgios |
| Affiliation: | 1.Institute of Life Sciences, Scuola Superiore Sant’Anna, Piazza Martiri della Libertà 33, 56124, Pisa, Italy ;2.Cardiology Division, University Hospital of Pisa, Piazza Martiri della Libertà 33, 56124, Pisa, Italy ;3.Department of Biostatistics and Research Support, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands ;4.Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece ;5.Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain ;6.CIBER Cardiovascular, Instituto de Salud Carlos III, Madrid, Spain ;7.Department of Medical and Surgical Specialties, Radiological Sciences, Public Health University and Civil Hospital, Brescia, Italy ;8.Cardiology Department, Fondazione Toscana Gabriele Monasterio, Pisa, Italy ;9.School of Biomedical Engineering and Imaging Sciences, King’s College London, London, UK ; |
| Abstract: | Cardiovascular Drugs and Therapy - Sacubitril/valsartan, vericiguat, and the sodium-glucose co-transporter-2 inhibitors (SGLT2i) dapagliflozin and empagliflozin proved effective in phase 3 trials... |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |